Key Updates
Palantir declined 2.18% to $126.81 since the June 10 report, extending losses to nine consecutive sessions and breaking through the critical $130 support level that had held during the May consolidation period. The stock now trades 28.66% below its 2026 opening level and 30.92% below its six-month high, representing a shift from technical consolidation to confirmed downtrend. New developments include Michael Burry's disclosed short position citing massive overvaluation, escalating political controversy over UK government contracts worth £600 million, and confirmation that the stock traded above $160 as recently as late May before the current decline accelerated.
Current Trend
Palantir has entered a confirmed downtrend with YTD losses of 28.66% and six-month losses of 30.92%. The stock has broken decisively below the $130-$160 consolidation range identified in late May technical analysis, with the $130 support level now acting as overhead resistance. The nine-day losing streak represents significant momentum deterioration from the $160+ levels where the stock traded in late May. Near-term resistance sits at $130 (former support), while the next technical support zone appears at $120. The 6.43% decline over five days demonstrates accelerating downside momentum compared to the 2.49% monthly decline, indicating intensifying selling pressure.
Investment Thesis
The investment thesis centers on Palantir's positioning as a dominant AI infrastructure provider with exceptional unit economics and government contract durability. Core strengths include approximately 80% gross margins, positive free cash flow generation, and the $10 billion, 10-year U.S. Army contract signed in July 2025. The AIP platform has compressed enterprise sales cycles to under five days and driven 93% year-over-year commercial revenue growth. The company achieved a Rule of 40 score of 94%, combining sustainable revenue growth with profitability. However, this thesis faces mounting challenges from valuation concerns—with the company trading at premiums Bank of America characterizes as "at least 50% above fair value"—and emerging political risks that threaten the £600 million UK contract portfolio following London's mayor blocking a £50 million Metropolitan Police deal.
Thesis Status
The investment thesis has materially weakened since the previous report. While fundamental business metrics remain strong with the company surpassing $1 billion in quarterly revenue for the first time and maintaining exceptional margins, the 30.92% six-month decline suggests the market is aggressively repricing valuation multiples. Michael Burry's disclosed short position adds credibility to concerns that the $375 billion valuation (23rd globally) cannot be sustained for a company too small to qualify for the Fortune 500. The political controversy surrounding UK contracts introduces execution risk not previously factored into the thesis, with nearly 250,000 petition signers opposing government contracts and MPs raising data sovereignty concerns. The breakdown below the $130-$160 consolidation range invalidates the May technical setup for an upside breakout, suggesting the market no longer supports premium valuations despite strong operational performance.
Key Drivers
The primary negative driver is valuation compression, with Michael Burry's short position signaling institutional skepticism about the $375 billion market capitalization. Political headwinds have intensified with London's mayor blocking a £50 million Metropolitan Police contract and nearly 250,000 petition signers opposing UK government deals worth £600 million across NHS, Ministry of Defence, and police forces. Positive catalysts include the $10 billion, 10-year U.S. Army contract and 93% year-over-year commercial revenue growth driven by AIP platform adoption. The CHIPS Act federal spending exceeding $2 billion for domestic deep-tech infrastructure represents a potential long-term tailwind.
Technical Analysis
Palantir has broken down from the $130-$160 consolidation range that persisted through May, with the stock declining from above $160 to $126.81 over approximately two weeks. The $130 level, previously identified as support in the CNBC analysis, has failed decisively and now represents overhead resistance. The nine-day losing streak and accelerating decline velocity (6.43% over five days versus 2.49% over one month) indicate strong downside momentum. The stock has retraced 30.92% from its six-month high, approaching oversold conditions but showing no signs of stabilization. Volume and momentum indicators suggest continued selling pressure, with no clear support level until the $120 zone. The failed breakout setup from late May has transformed into a breakdown pattern, with the next resistance zone at $130-$135.
Bull Case
- Rule of 40 score of 94% demonstrates exceptional balance of revenue growth and profitability, indicating sustainable business model execution without sacrificing margins for expansion
- $10 billion, 10-year U.S. Army contract signed in July 2025 provides substantial revenue visibility and validates the platform's mission-critical status for defense applications
- 93% year-over-year commercial revenue growth driven by AIP platform demonstrates successful expansion beyond government contracts into higher-margin enterprise markets
- Approximately 80% gross margins and positive free cash flow with enterprise sales cycles compressed to under five days through AIP bootcamps represent best-in-class unit economics
- Positioning to benefit from over $2 billion in CHIPS Act federal spending on domestic deep-tech infrastructure provides long-term government spending tailwind
Bear Case
- Michael Burry's short position arguing massive overvaluation adds institutional credibility to concerns that $375 billion market cap cannot be justified for a company too small for Fortune 500
- Bank of America Securities indicates trading at least 50% above fair value based on traditional valuation metrics, suggesting significant downside risk from multiple compression
- London's mayor blocked £50 million Metropolitan Police contract and nearly 250,000 petition signers oppose UK government contracts, threatening £600 million in revenue across NHS, Ministry of Defence, and police forces
- MPs raising data sovereignty concerns and CEO positioning as "completely anti-woke" creates political and reputational risks that could limit future government contract opportunities in international markets
- Technical breakdown below $130-$160 consolidation range with nine consecutive down sessions and 30.92% six-month decline indicates sustained institutional selling and momentum deterioration from $160+ levels reached in late May